- 专利标题： AMINOQUINAZOLINE COMPOUNDS AS A2A ANTAGONIST
-
申请号： US15549242申请日： 2016-02-01
-
公开(公告)号： US20180037554A1公开(公告)日： 2018-02-08
- 发明人: Amjad Ali , Rongze Kuang , Yeon-Hee Lim , Michael Man-Chu Lo , Pauline C. Ting , Purakkattle Biju , Manuel de Lera Ruiz , Sylvia J. Degrado , Alexander L. Tung , Timothy J. Henderson , Liwu Hong , Jae-Hun Kim , Dong Won-Shik Kim , Joe Lee , Jie Wu , Heping Wu , Yushi Xiao , Tao Yu , Gang Zhou , Xiaohong Zhu , Kevin D. McCormick , Jayaram R. Tagat , Dong Xiao , Tanweer Khan , Jianhua Cao , Michael Berlin , Yonglian Zhang
- 申请人： Merck Sharp & Dohme Corp.
- 申请人地址： US NJ Rahway
- 专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人： Merck Sharp & Dohme Corp.
- 当前专利权人地址： US NJ Rahway
- 国际申请： PCT/US16/15881 WO 20160201
- 主分类号： C07D239/84
- IPC分类号： C07D239/84 ; C07D401/14 ; C07D413/12 ; C07D417/12 ; C07D405/12 ; C07D417/14 ; C07D413/14 ; C07D471/04 ; C07D401/12 ; C07D403/12
摘要：
The present invention is directed to compounds of generic formula I: or pharmaceutically acceptable salts thereof that are believed to be useful as an A2A-receptor antagonist.
公开/授权文献
- US10138212B2 Aminoquinazoline compounds as A2A antagonist 公开/授权日：2018-11-27
信息查询
